rs2227567

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002658.6(PLAU):​c.691A>C​(p.Lys231Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00978 in 1,613,688 control chromosomes in the GnomAD database, including 1,010 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.045 ( 503 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 507 hom. )

Consequence

PLAU
NM_002658.6 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.794

Publications

13 publications found
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001355797).
BP6
Variant 10-73913990-A-C is Benign according to our data. Variant chr10-73913990-A-C is described in ClinVar as Benign. ClinVar VariationId is 300753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.149 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002658.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLAU
NM_002658.6
MANE Select
c.691A>Cp.Lys231Gln
missense
Exon 8 of 11NP_002649.2
PLAU
NM_001441154.1
c.691A>Cp.Lys231Gln
missense
Exon 9 of 12NP_001428083.1
PLAU
NM_001441155.1
c.691A>Cp.Lys231Gln
missense
Exon 8 of 11NP_001428084.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLAU
ENST00000372764.4
TSL:1 MANE Select
c.691A>Cp.Lys231Gln
missense
Exon 8 of 11ENSP00000361850.3
C10orf55
ENST00000409178.5
TSL:1
n.269-915T>G
intron
N/A
PLAU
ENST00000446342.5
TSL:2
c.640A>Cp.Lys214Gln
missense
Exon 7 of 10ENSP00000388474.1

Frequencies

GnomAD3 genomes
AF:
0.0449
AC:
6834
AN:
152170
Hom.:
498
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0196
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0273
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000573
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.0149
AC:
3740
AN:
251332
AF XY:
0.0124
show subpopulations
Gnomad AFR exome
AF:
0.158
Gnomad AMR exome
AF:
0.00755
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.000431
Gnomad OTH exome
AF:
0.00701
GnomAD4 exome
AF:
0.00611
AC:
8928
AN:
1461400
Hom.:
507
Cov.:
32
AF XY:
0.00613
AC XY:
4458
AN XY:
727026
show subpopulations
African (AFR)
AF:
0.157
AC:
5268
AN:
33450
American (AMR)
AF:
0.00850
AC:
380
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00165
AC:
43
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0247
AC:
2134
AN:
86244
European-Finnish (FIN)
AF:
0.000356
AC:
19
AN:
53400
Middle Eastern (MID)
AF:
0.0101
AC:
58
AN:
5766
European-Non Finnish (NFE)
AF:
0.000246
AC:
274
AN:
1111606
Other (OTH)
AF:
0.0125
AC:
752
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
450
900
1350
1800
2250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0450
AC:
6855
AN:
152288
Hom.:
503
Cov.:
33
AF XY:
0.0437
AC XY:
3255
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.153
AC:
6334
AN:
41534
American (AMR)
AF:
0.0195
AC:
299
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5184
South Asian (SAS)
AF:
0.0269
AC:
130
AN:
4830
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000573
AC:
39
AN:
68018
Other (OTH)
AF:
0.0213
AC:
45
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
301
602
903
1204
1505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0143
Hom.:
366
Bravo
AF:
0.0516
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.149
AC:
657
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.0183
AC:
2217
Asia WGS
AF:
0.0220
AC:
76
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
Quebec platelet disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.22
DANN
Benign
0.52
DEOGEN2
Benign
0.19
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.0014
T
MetaSVM
Benign
-0.98
T
PhyloP100
-0.79
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.24
N
REVEL
Benign
0.0060
Sift
Benign
0.40
T
Sift4G
Benign
0.61
T
Polyphen
0.0020
B
Vest4
0.071
MPC
0.30
ClinPred
0.0023
T
GERP RS
-5.3
gMVP
0.39
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2227567; hg19: chr10-75673748; API